Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndrome .
CONCLUSION: A PPK model of tacrolimus in children with nephrotic syndrome was developed. Age and bodyweight could partly explain the interindividual variability in the CL/F and V/F of tacrolimus. The final model could be used to accurately predict tacrolimus individual pharmacokinetic parameters and assist in dosage optimization.
.
PMID: 30663980 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research
More News: Children | China Health | Drugs & Pharmacology | Nephrotic Syndrome | Pediatrics | Prograf | Study | Tacrolimus